Kirke Weaver compensation by year
Organon Summary Compensation Table · all 2 fiscal years held| Component | FY2023 | FY2025 |
|---|---|---|
| Salary | $650,000 | $676,923 |
| Bonus | $210,656 | $0 |
| Stock awards | $1,314,174 | $1,734,932 |
| Option awards | $437,394 | $550,000 |
| Non-equity incentive | $445,900 | $394,560 |
| Pension and deferred compensation | $0 | $0 |
| All other | $134,569 | $186,560 |
| Total | $3,192,693 | $3,542,975 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Organon & Co. DEF 14A filed April 24, 2026, accession 0001193125-26-177411, and prior-year filings.
How this page was built: the Organon & Co. filed document, accession 0001193125-26-177411. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 73,875 | $529,684 | — |
| PSU | 46,542 | $333,706 | — |
| RSU | 36,937 | $264,838 | — |
| RSU | 15,514 | $111,235 | — |
| RSU | 6,201 | $44,461 | — |
| Option | 181,518 | — | $14.89 |
| Option | 22,265 | — | $23.52 |
| Option | 63,544 | — | $18.80 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Organon & Co.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Change-in-control & termination
estimated payments Organon discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Change in control and involuntary termination | $2,466,000 | $1,343,277 | $88,214 | $4,445,491 |
| Involuntary termination without cause | $1,549,154 | $470,068 | $58,451 | $2,625,673 |
| Change in control, no termination | — | $682,475 | — | — |
| Disability | — | $470,068 | — | $470,068 |
| Death | — | $470,068 | — | $470,068 |
| Change in control and resignation for good reason | $2,466,000 | $1,343,277 | $88,214 | $3,102,214 |
| Retirement | — | $470,068 | — | $470,068 |
Per the Potential Payments Upon Termination or Change in Control table in Organon & Co.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
Organon’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Kevin Ali | Former Chief Executive Officer | $15,813,296 |
| Joseph Morrissey | Interim Chief Executive Officer | $5,772,848 |
| Matthew Walsh | EVP and Chief Financial Officer | $5,686,204 |
| Juan Camilo Arjona Ferreira | EVP and Head of R&D and Chief Medical Officer | $3,822,487 |
| Rachel Stahler | EVP and Chief Digital & Growth Officer | $3,551,619 |
| Kirke Weaver · this page | EVP, General Counsel and Corporate Secretary | $3,542,975 |
Kirke Weaver's compensation dossier, Organon
You have read Kirke Weaver's totals and holdings. The dossier adds each equity grant Organon disclosed for Kirke Weaver and Organon's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full Organon compensation record
free company briefThis page is one person within Organon's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Organon proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Organon's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Organon's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.